2Artificial Intelligence and Machine Learning-Based New Drug Discovery Process with Molecular Modelling
Isha Rani1, Kavita Munjal2, Rajeev K. Singla3,4 and Rupesh K. Gautam5*
1Spurthy College of Pharmacy, Marasur Gate, Bengaluru, Karnataka, India
2MM College of Pharmacy, MM (Deemed to be) University-Mullana, Ambala, Haryana, India
3Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China
4iGlobal Research and Publishing Foundation, New Delhi, India
5Department of Pharmacology, Indore Institute of Pharmacy, IIST Campus, Rau, Indore (M.P.), India
Abstract
Drug development is a time-consuming, expensive and extremely risky procedure. Up to 90% of drug concepts are discarded due to challenges such as safety, efficacy and toxicity resulting in significant losses for the investor. The use of artificial intelligence (AI), namely machine learning and deep learning algorithms, to improve the drug discovery process is one technique that has arisen in recent years. AI has been effectively used in drug discovery and design. This chapter includes these machine learning approaches in depth, as well as their applications in medicinal chemistry. The current state-of-the-art of AI supported pharmaceutical discovery is discussed, including applications in structure and ligand-based virtual screening, de novo drug design, drug repurposing, and factors related, after introducing the basic principles, ...
Get Bioinformatics Tools for Pharmaceutical Drug Product Development now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.